SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 652.25 |
Enterprise Value ($M) | 661.88 |
Book Value ($M) | 121.86 |
Book Value / Share | 0.88 |
Price / Book | 5.35 |
NCAV ($M) | 109.75 |
NCAV / Share | 0.79 |
Price / NCAV | 5.94 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.43 |
Return on Assets (ROA) | -0.50 |
Return on Equity (ROE) | -0.66 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 14.90 |
Current Ratio | 14.90 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 146.19 |
Assets | 158.29 |
Liabilities | 36.43 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -59.21 |
Net Income | -54.70 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -51.06 |
Cash from Investing | -57.12 |
Cash from Financing | 82.78 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Bain Capital Life Sciences Fund II, L.P. | 9.99 | 2.34 | |
13G/A | Venrock Healthcare Capital Partners II, L.P. | 2.60 | -44.90 | |
13G/A | Zambon Spa | 3.46 | -0.29 | |
13G/A | Caxton Corp | 0.30 | -94.88 | |
13G | Prudential Financial Inc | 7.23 | ||
13G | Jennison Associates Llc | 6.50 | ||
13G/A | Adage Capital Partners Gp, L.l.c. | 5.64 | 11.27 | |
13G/A | Farallon Capital Partners, L.P. | 9.99 | 24.23 | |
13G | BlackRock Inc. | 5.40 | 132.07 | |
13D/A | Growth Equity Opportunities 17, LLC | 18.10 | 1.38 | |
13G | TCG Crossover GP I, LLC | 7.40 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
160,471 | 742,222 | 21.62 | |
84,263 | 373,729 | 22.55 | |
96,963 | 669,384 | 14.49 | |
107,154 | 685,328 | 15.64 | |
163,969 | 699,764 | 23.43 | |
(click for more detail) |
Similar Companies | |
---|---|
SRRK – Scholar Rock Holding Corporation | STOK – Stoke Therapeutics, Inc. |
STTK – Shattuck Labs, Inc. | SWTX – SpringWorks Therapeutics, Inc. |
SYRE – Spyre Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io